President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...
The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...
The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback